Skip to main content
TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
77.20
-5.72 (-6.90%)
At close: Nov 20, 2024, 4:00 PM
77.00
-0.20 (-0.26%)
Pre-market: Nov 21, 2024, 7:41 AM EST

TransMedics Group Revenue

TransMedics Group had revenue of $108.76M in the quarter ending September 30, 2024, with 63.72% growth. This brings the company's revenue in the last twelve months to $401.09M, up 109.09% year-over-year. In the year 2023, TransMedics Group had annual revenue of $241.62M with 158.53% growth.

Revenue (ttm)
$401.09M
Revenue Growth
+109.09%
P/S Ratio
6.35
Revenue / Employee
$686,798
Employees
584
Market Cap
2.59B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023241.62M148.16M158.53%
Dec 31, 202293.46M63.20M208.83%
Dec 31, 202130.26M4.62M18.03%
Dec 31, 202025.64M2.04M8.62%
Dec 28, 201923.60M10.59M81.33%
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 30, 2006 Pro Pro Pro
Dec 31, 2005 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
PACS Group 3.56B
Surgery Partners 2.99B
Amneal Pharmaceuticals 2.68B
Concentra Group Holdings Parent 1.88B
LifeStance Health Group 1.21B
ACADIA Pharmaceuticals 929.24M
Warby Parker 742.53M
Vericel 226.84M
Revenue Rankings

TMDX News

More News